Larry W. Papasan is Director at BIOMIMETIC THERAPEUTICS, INC. (BMTI). They have made 8 open-market trades across 4 companies since 2007, most recently 2017-10-30.
CIK 0001281239
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
5 open-market purchases totalling $173K since 2007, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| MDXG | SELL | 2015-05-28 | 2015-05-29 | $10.09 | $60K | -7.9% | -2.1% | -2.1% |
| BMTI | BUY | 2012-03-27 | 2012-03-29 | $2.33 | $17K | N/A | N/A | N/A |
| UTG | BUY | 2011-12-21 | 2011-12-22 | $25.86 | $26K | -2.6% | +0.1% | +0.1% |
| BMTI | SELL | 2011-06-10 | 2011-06-14 | $5.70 | $37K | N/A | N/A | N/A |
| UTG | SELL | 2010-08-09 | 2010-10-28 | $20.92 | $21K | -2.6% | +0.1% | +0.1% |
| MDXG.OB | BUY | 2009-11-19 | 2009-11-20 | $0.60 | $25K | N/A | N/A | N/A |
| MDXG.OB | BUY | 2009-10-19 | 2009-10-21 | $0.45 | $8K | N/A | N/A | N/A |
| BMTI | BUY | 2007-09-11 | 2007-12-19 | $14.98 | $97K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.